Files / Presentation
18th ICRT
| Topic (ID) | Submission ID. Title | |
|---|---|---|
| Theragnostics | 13. News from Theragnostics in Children with Neuroblastoma | |
| 20. 3p-C-NETA-TATE: A potential somatostatin analogue for diagnostic and therapeutic SSTR2 targeting radiopharmaceuticals | ||
| 22. RADIONUCLIDIC “FORCE MULTIPLICATION” IN IMMUNOLOGICAL ANTI CANCER THERAPY | ||
| 24. 177Lu-PSMA-617 IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER: EXPERIENCE IN URUGUAY | ||
| 26. Diagnostic Performance of Tc-99m Bone Scintigraphy in the Staging of Prostate Cancer | ||
| 27. Comparison of two dosimetry software programs for Lu-177 DOTATATE therapy using patient-specific voxel-based phantom models. | ||
| 37. Lu-177 PSMA as salvage therapy for Hepatocellular carcinoma | ||
| 40. Evaluation of the added value of a diuretic renogram in the assessment of renal function prior to targeted radionuclide therapy. | ||
| 45. Overview of radiopharmaceutical therapy in Ghana | ||
| Prostate | 8. Initial Response to 177Lu-PSMA Radioligand Therapy in Chemotherapy-naïve Patients | |
| 18. Role of Ga68-PSMA in the management of Prostate cancer | ||
| 24. 177Lu-PSMA-617 IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER: EXPERIENCE IN URUGUAY | ||
| 26. Diagnostic Performance of Tc-99m Bone Scintigraphy in the Staging of Prostate Cancer | ||
| 40. Evaluation of the added value of a diuretic renogram in the assessment of renal function prior to targeted radionuclide therapy. | ||
| NETS | 3. An in-house developed dosimetry software for lutetium-177: Masterdose | |
| 4. Efficacy of second 177Lu-DOTATATE PRRT course in patients with progressive GEP-NET using dual-tracer imaging with 18FDG and 68Ga-DOTA-TOC/TATE PET/CT. Results of a WARMTH multicenter study. | ||
| 14. Utility of NETPET in identification of patients suitable for Lu-177 DOTATATE radionuclide therapy | ||
| 19. Role of Ga68-Dotatoc the management of Neuroendocrine tumors | ||
| 20. 3p-C-NETA-TATE: A potential somatostatin analogue for diagnostic and therapeutic SSTR2 targeting radiopharmaceuticals | ||
| 38. Ga-68 DOTATATE Avid Ectopic Adrenocorticotropic Hormone Secreting Pulmonary Carcinoid Tumour detected on PET/CT | ||
| 40. Evaluation of the added value of a diuretic renogram in the assessment of renal function prior to targeted radionuclide therapy. | ||
| Alpha | 5. Effectiveness of neoadjuvant [225Ac] Ac-DOTATATE therapy in inoperable locally advanced somatostatin receptor-expressing meningioma | |
| 21. In-house production of various forms of [225Ac]Ac-PSMA injection – a South African hospital experience | ||
| Policy | 15. Designing a PET/CT Facility integrated within the General Nuclear Medicine Department at Groote Schuur Hospital | |
| Thyroid (6) | 2. Treatment of papillary thyroid microcarcinoma metastasis to the sternum: a case report. | |
| 6. Review of international (ATA 2015 and ETA 2022) and Russian recommendations for radioiodine therapy in children with differentiated thyroid cancer. | ||
| 11. LONG TERM FOLLOW UP OF DIFFERENTIATED THYROID CARCINOMA IN A SPECIALIZED ONCOLOGICAL CENTER: IMPACT OF RADIOIODINE THERAPY | ||
| 17. Crucial role of Iodine 131 in the Management of bone metastasis of differentiated thyroid cancer | ||
| 30. EFFECT OF A SINGLE DOSE OF RADIOIODINE THERAPY ON PRIMARY HYPERTHYROIDISM PATIENTS IN GHANA. | ||
| 45. Overview of radiopharmaceutical therapy in Ghana | ||
| 46. DURATION AND FACTORS AFFECTING THE OUTCOME OF RADIOIODINE TREATMENT OF HYPERTHYROIDISM | ||
| 47. Toxic retrosternal goitre treated with radioiodine- a case report | ||
| 48. Paradoxical decrease in TSH level during thyroxine withdrawal for radioiodine therapy for well differentiated thyroid cancer- a case report | ||
| 49. A clinical and ethical dilemma during radioiodine therapy for well differentiated thyroid cancer- a case report | ||
| 50. Radioiodine therapy in a thyrotoxic heart disease unfit for surgery- a case report | ||
| Other | 7. Can FDG PET/CT be used to optimize the treatment of patients with pulmonary tuberculosis? | |
| 9. Imaging of PARP upregulation in small cell neuroendocrine lung carcinoma with [123I] I-PARPi SPECT/CT | ||
| 10. Breast Cancer: Advantages in the Acquisition of Pendulous Images over Supine Images with 18 FDG PET CT in Restaging Breast Lesions | ||
| 15. Designing a PET/CT Facility integrated within the General Nuclear Medicine Department at Groote Schuur Hospital | ||
| 16. Evaluate the Slab Thickness of the new LINAC Bunker as Shielding at the INMP, AERE, BAEC, Bangladesh | ||
| 25. Comparative analysis and experience of various amino acid PET tracers in a tertiary neurooncology center – indications, patterns, advantages and pitfalls. | ||
| 28. The cancer-associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia-inducible factor-1alpha immunohistochemistry | ||
| 29. Multimodality Imaging Possibilities of Therapeutic Isotopes in the Preclinical Setting | ||
| 33. ARTIFICIAL INTELLIGENCE IN THORACIC IMAGING IN ABIDJAN: USE OF COMPUTER-AIDED DIAGNOSIS DURING IMAGE POST-PROCESSING BY RADIOLOGISTS. | ||
| 35. POST-RECONSTRUCTION METHOD TO CORRECT PARTIAL VOLUME EFFECT IN SPECT IMAGING | ||
| 39. Regadenoson compared to other pharmacological stressors used in myocardial perfusion imaging (MPI) at the Department of Nuclear Medicine at a Tertiary Academic Hospital in Gauteng, South Africa. | ||
| 42. Should 18F-FDG PET/CT scans (2-deoxy-2[fluorine 18] fluoro-D-glucose integrated with computed tomography) replace 99m Tc-MDP (methylene diphosphonate) bone scintigraphy in the management of breast cancer patients with suspected skeletal metastases? | ||
| Diagnostics | 1. Physiological F-18 FDG Uptake in Normal Pituitary Gland on Digital PET Scanner | |
| 12. The added value of SPECT/CT in pediatric transplant renography - a case report | ||
| 23. Hyperparathyroidism and multiple pathological fractures caused by parathyroid carcinoma: A case report | ||
| 25. Comparative analysis and experience of various amino acid PET tracers in a tertiary neurooncology centre – indications, patterns, advantages, and pitfalls. | ||
| 31. CONTRIBUTION OF BONE RADIONUCLIDE IMAGING IN THE ETIOLOGICAL DIAGNOSIS OF A KNEE TUMOR: A CASE REPORT | ||
| 32. CONTRIBUTION OF Tc99m-Labelled MIBI SCINTIGRAPHY IN THE DIAGNOSIS OF PARATHYROIDAL ADENOMY A CASE STUDY | ||
| 34. INCIDENTAL MYOCARDIAL FIXATION ON BISPHOSPHONATE BONE SCAN: TWO CASES | ||
| 36. Hepatobiliary study showing bile reflux into the gastric mucosa | ||
| 41. Does bone scintigraphy change clinical management in patients with Lung cancer | ||
| 32. CONTRIBUTION OF Tc99m-Labelled MIBI SCINTIGRAPHY IN THE DIAGNOSIS OF PARATHYROIDAL ADENOMY A CASE STUDY | ||
| Author | Submission ID. Title |
|---|---|
| Sofiullah Abubakar | 1. Physiological F-18 FDG Uptake in Normal Pituitary Gland on Digital PET Scanner |
| SANDEEP AGARWAL | 22. RADIONUCLIDIC “FORCE MULTIPLICATION” IN IMMUNOLOGICAL ANTI CANCER THERAPY |
| Mariela Agolti | 10. Breast Cancer: Advantages in the Acquisition of Pendulous Images over Supine Images with 18 FDG PET CT in Restaging Breast Lesions |
| M Monjur Ahasan | 16. Evaluate the Slab Thickness of the new LINAC Bunker as Shielding at the INMP, AERE, BAEC, Bangladesh |
| Stephen Ahenkorah | 20. 3p-C-NETA-TATE: A potential somatostatin analogue for diagnostic and therapeutic SSTR2 targeting radiopharmaceuticals |
| Joel Eduardo Vargas Ahumada | . LONG TERM FOLLOW UP OF DIFFERENTIATED THYROID CARCINOMA IN A SPECIALIZED ONCOLOGICAL CENTER: IMPACT OF RADIOIODINE THERAPY |
| Asiya Al Busaidi | 1. Physiological F-18 FDG Uptake in Normal Pituitary Gland on Digital PET Scanner |
| Abdulilah Al Nabulsi | 14. Utility of NETPET in identification of patients suitable for Lu-177 DOTATATE radionuclide therapy |
| Khulood Al Riyami | 1. Physiological F-18 FDG Uptake in Normal Pituitary Gland on Digital PET Scanner |
| Koffi N'guessan Placide Gabin ALLANGBA | 35. POST-RECONSTRUCTION METHOD TO CORRECT PARTIAL VOLUME EFFECT IN SPECT IMAGING |
| Omar Alonso | 24. 177Lu-PSMA-617 IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER: EXPERIENCE IN URUGUAY |
| Assia Amimour | 17. Crucial role of Iodine 131 in Management of bone metastasis of differentiated thyroid cancer |
| Alfred Ankrah | 45. Overview of radiopharmaceutical therapy in Ghana |
| 46. DURATION AND FACTORS AFFECTING THE OUTCOME OF RADIOIODINE TREATMENT OF HYPERTHYROIDISM | |
| 47. Toxic retrosternal goitre treated with radioiodine- a case report | |
| 48. Paradoxical decrease in TSH level during thyroxine withdrawal for radioiodine therapy for well differentiated thyroid cancer- a case report | |
| 49. A clinical and ethical dilemma during radioiodine therapy for well differentiated thyroid cancer- a case report | |
| 50. Radioiodine therapy in a thyrotoxic heart disease unfit for surgery- a case report | |
| 30. EFFECT OF A SINGLE DOSE OF RADIOIODINE THERAPY ON PRIMARY HYPERTHYROIDISM PATIENTS IN GHANA. | |
| Sviridenko Anna | 13. News from Theragnostics in Children with Neuroblastoma |
| Akinwale Ayeni | 14. Utility of NETPET in identification of patients suitable for Lu-177 DOTATATE radionuclide therapy |
| Hafiza Aziz | 15. Designing a PET/CT Facility integrated within the General Nuclear Medicine Department at Groote Schuur Hospital |
| Shona Badhree | 37. Lu-177 PSMA as salvage therapy for Hepatocellular carcinoma |
| Agustina Banchero | 24. 177Lu-PSMA-617 IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER: EXPERIENCE IN URUGUAY |
| Richard Baum | 4. Efficacy of second 177Lu-DOTATATE PRRT course in patients with progressive GEP-NET using dual-tracer imaging with 18FDG and 68Ga-DOTA-TOC/TATE PET/CT. Results of a WARMTH multicenter study. |
| leila Benrabah | 19. Role of Ga68-Dotatoc the management of Neuroendocrine tumors |
| Meshack Bida | 9. Imaging of PARP upregulation in small cell neuroendocrine lung carcinoma with [123I] I-PARPi SPECT/CT |
| 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry | |
| Gaseeda Boltman | 15. Designing a PET/CT Facility integrated within the General Nuclear Medicine Department at Groote Schuur Hospital |
| Guy Bormans | 20. 3p-C-NETA-TATE: A potential somatostatin analogue for diagnostic and therapeutic SSTR2 targeting radiopharmaceuticals |
| Imene Bougara | 19. Role of Ga68-Dotatoc the management of Neuroendocrine tumors |
| Salah Bouyoucef | 17. Crucial role of Iodine 131 in Management of bone metastasis of differentiated thyroid cancer |
| 18. Role of Ga68-PSMA in the management of Prostate cancer | |
| 19. Role of Ga68-Dotatoc the management of Neuroendocrine tumors | |
| Anita Brink | 12. The added value of SPECT/CT in paediatric transplant renography - a case report |
| Nanette Bruwer | 15. Designing a PET/CT Facility integrated within the General Nuclear Medicine Department at Groote Schuur Hospital |
| Ana Lucía Calderón Ávila | 11. LONG TERM FOLLOW UP OF DIFFERENTIATED THYROID CARCINOMA IN A SPECIALIZED ONCOLOGICAL CENTER: IMPACT OF RADIOIODINE THERAPY |
| Thomas Cardinaels | 20. 3p-C-NETA-TATE: A potential somatostatin analogue for diagnostic and therapeutic SSTR2 targeting radiopharmaceuticals |
| Cawthorne Christopher | 20. 3p-C-NETA-TATE: A potential somatostatin analogue for diagnostic and therapeutic SSTR2 targeting radiopharmaceuticals |
| Frederik Cleeren | 20. 3p-C-NETA-TATE: A potential somatostatin analogue for diagnostic and therapeutic SSTR2 targeting radiopharmaceuticals |
| Korsah Clement | 30. EFFECT OF A SINGLE DOSE OF RADIOIODINE THERAPY ON PRIMARY HYPERTHYROIDISM PATIENTS IN GHANA. |
| Ismael Cordero | 24. 177Lu-PSMA-617 IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER: EXPERIENCE IN URUGUAY |
| Cindy Davis | 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry |
| Christophe M Deroose | 20. 3p-C-NETA-TATE: A potential somatostatin analogue for diagnostic and therapeutic SSTR2 targeting radiopharmaceuticals |
| Gianpaolo Di Santo | 13. News from Theragnostics in Children with Neuroblastoma |
| Dineo Disenyane | 9. Imaging of PARP upregulation in small cell neuroendocrine lung carcinoma with [123I] I-PARPi SPECT/CT |
| ALLOKOU LANDRY CHRISTIAN DJOBO | 34. INCIDENTAL MYOCARDIAL FIXATION ON BISPHOSPHONATE BONE SCAN: TWO CASES |
| 31. CONTRIBUTION OF BONE RADIONUCLIDE IMAGING IN THE ETIOLOGICAL DIAGNOSIS OF A KNEE TUMOR: A CASE REPORT | |
| Boris Dolgushin | 6. Review of international (ATA 2015 and ETA 2022) and Russian recommendations for radioiodine therapy in children with differentiated thyroid cancer. |
| Gerardo dos Santos | 24. 177Lu-PSMA-617 IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER: EXPERIENCE IN URUGUAY |
| Cathryn Helena Sanford Driver | 29. Multimodality Imaging Possibilities of Therapeutic Isotopes in the Preclinical Setting |
| Hanlie Du Raan | 27. Comparison of two dosimetry software programs for Lu-177 DOTATATE therapy using patient-specific voxel-based phantom models. |
| Pablo Duarte | 24. 177Lu-PSMA-617 IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER: EXPERIENCE IN URUGUAY |
| FATURRAHMAN FATURRAHMAN | 23. Hyperparathyroidism and multiple pathological fracture caused by parathyroid carcinoma : A case report |
| Lerato Gabela | 38. Ga-68 DOTATATE Avid Ectopic Adrenocorticotropic Hormone Secreting Pulmonary Carcinoid Tumour detected on PET/CT |
| 40. Evaluation of the added value of a diuretic renogram in the assessment of renal function prior to targeted radionuclide therapy. | |
| 44. The case of multiple periarticular masses on bone scan | |
| Juan Pablo Gambini | 24. 177Lu-PSMA-617 IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER: EXPERIENCE IN URUGUAY |
| Francisco Osvaldo García Pérez | 11. LONG TERM FOLLOW UP OF DIFFERENTIATED THYROID CARCINOMA IN A SPECIALIZED ONCOLOGICAL CENTER: IMPACT OF RADIOIODINE THERAPY |
| Tamara Geliashvili | 2. Treatment of papillary thyroid microcarcinoma metastasis to the sternum: a case report. |
| 6. Review of international (ATA 2015 and ETA 2022) and Russian recommendations for radioiodine therapy in children with differentiated thyroid cancer. | |
| Frederik Giesel | 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry |
| Alessia GIULIANO | 35. POST-RECONSTRUCTION METHOD TO CORRECT PARTIAL VOLUME EFFECT IN SPECT IMAGING |
| Edgar Valentín Gómez Argumosa | 11. LONG TERM FOLLOW UP OF DIFFERENTIATED THYROID CARCINOMA IN A SPECIALIZED ONCOLOGICAL CENTER: IMPACT OF RADIOIODINE THERAPY |
| Mikhail Goncharov | 6. Review of international (ATA 2015 and ETA 2022) and Russian recommendations for radioiodine therapy in children with differentiated thyroid cancer. |
| Sofía Denisse González Rueda | 11. LONG TERM FOLLOW UP OF DIFFERENTIATED THYROID CARCINOMA IN A SPECIALIZED ONCOLOGICAL CENTER: IMPACT OF RADIOIODINE THERAPY |
| Chiara Maria Grana | 4. Efficacy of second 177Lu-DOTATATE PRRT course in patients with progressive GEP-NET using dual-tracer imaging with 18FDG and 68Ga-DOTA-TOC/TATE PET/CT. Results of a WARMTH multicenter study. |
| Bawanile Hadebe | 38. Ga-68 DOTATATE Avid Ectopic Adrenocorticotropic Hormone Secreting Pulmonary Carcinoid Tumour detected on PET/CT |
| Bawanile Hadebe | 42. Should 18F-FDG PET/CT scans (2-deoxy-2[fluorine 18] fluoro-D-glucose integrated with computed tomography) replace 99m Tc-MDP (methylene diphosphonate) bone scintigraphy in the management of breast cancer patients with suspected skeletal metastases? |
| Trisha Hambapersad | 36. Hepatobiliary study showing bile reflux into the gastric mucosa |
| Emmanuel Hammond | 46. DURATION AND FACTORS AFFECTING THE OUTCOME OF RADIOIODINE TREATMENT OF HYPERTHYROIDISM |
| 48. Paradoxical decrease in TSH level during thyroxine withdrawal for radioiodine therapy for well differentiated thyroid cancer- a case report | |
| Lerwine Harry | 37. Lu-177 PSMA as salvage therapy for Hepatocellular carcinoma |
| Lerwine Harry | 38. Ga-68 DOTATATE Avid Ectopic Adrenocorticotropic Hormone Secreting Pulmonary Carcinoid Tumour detected on PET/CT |
| Lerwine Harry | 40. Evaluation of the added value of a diuretic renogram in the assessment of renal function prior to targeted radionuclide therapy. |
| Lerwine Harry | 42. Should 18F-FDG PET/CT scans (2-deoxy-2[fluorine 18] fluoro-D-glucose integrated with computed tomography) replace 99m Tc-MDP (methylene diphosphonate) bone scintigraphy in the management of breast cancer patients with suspected skeletal metastases? |
| 44. The case of multiple periarticular masses on bone scan | |
| Francis Hasford | 3. An in-house developed dosimetry software for lutetium-177: Masterdose |
| Abul Hasnat | 16. Evaluate the Slab Thickness of the new LINAC Bunker as Shielding at the INMP, AERE, BAEC, Bangladesh |
| DAYA HAZRA | 22. RADIONUCLIDIC “FORCE MULTIPLICATION” IN IMMUNOLOGICAL ANTI CANCER THERAPY |
| Chris Hikuam | 7. Can FDG PET/CT be used to optimize the treatment of patients with pulmonary tuberculosis? |
| Khanyisile Hlongwa | 12. The added value of SPECT/CT in paediatric transplant renography - a case report |
| 14. Utility of NETPET in identification of patients suitable for Lu-177 DOTATATE radionuclide therapy | |
| Khanyisile Hlongwa | 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry |
| Vadim Ilyakov | 2. Treatment of papillary thyroid microcarcinoma metastasis to the sternum: a case report. |
| Virgolini Irene | 13. News from Theragnostics in Children with Neuroblastoma |
| Aisha Ismaila | 7. Can FDG PET/CT be used to optimize the treatment of patients with pulmonary tuberculosis? |
| Nihaad Jacobs | 12. The added value of SPECT/CT in paediatric transplant renography - a case report |
| 14. Utility of NETPET in identification of patients suitable for Lu-177 DOTATATE radionuclide therapy | |
| Anjali Jain | 1. Physiological F-18 FDG Uptake in Normal Pituitary Gland on Digital PET Scanner |
| Levent Kabasakal | 4. Efficacy of second 177Lu-DOTATATE PRRT course in patients with progressive GEP-NET using dual-tracer imaging with 18FDG and 68Ga-DOTA-TOC/TATE PET/CT. Results of a WARMTH multicenter study. |
| Kalevi Kairemo | 4. Efficacy of second 177Lu-DOTATATE PRRT course in patients with progressive GEP-NET using dual-tracer imaging with 18FDG and 68Ga-DOTA-TOC/TATE PET/CT. Results of a WARMTH multicenter study. |
| Lusamba Noella Kashala | 36. Hepatobiliary study showing bile reflux into the gastric mucosa |
| SOULEYMANE KEITA | 31. CONTRIBUTION OF BONE RADIONUCLIDE IMAGING IN THE ETIOLOGICAL DIAGNOSIS OF A KNEE TUMOR: A CASE REPORT |
| 32. CONTRIBUTION OF Tc99m-Labelled MIBI SCINTIGRAPHY IN THE DIAGNOSIS OF PARATHYROIDAL ADENOMY A CASE STUDY | |
| 33. ARTIFICIAL INTELLIGENCE IN THORACIC IMAGING IN ABIDJAN: USE OF COMPUTER-AIDED DIAGNOSIS DURING IMAGE POST-PROCESSING BY RADIOLOGISTS. | |
| 34. INCIDENTAL MYOCARDIAL FIXATION ON BISPHOSPHONATE BONE SCAN: TWO CASES | |
| PADMAMALIKA KHANNA nee HAZRA | 22. RADIONUCLIDIC “FORCE MULTIPLICATION” IN IMMUNOLOGICAL ANTI CANCER THERAPY |
| Amel Khelifa | 17. Crucial role of Iodine 131 in Management of bone metastasis of differentiated thyroid cancer |
| Subhash kheruka | 1. Physiological F-18 FDG Uptake in Normal Pituitary Gland on Digital PET Scanner |
| Otto Knoesen | 21. In-house production of various forms of [225Ac]Ac-PSMA injection – a South African hospital experience |
| Olumayowa Kolade | 14. Utility of NETPET in identification of patients suitable for Lu-177 DOTATATE radionuclide therapy |
| ANHUM NICAISE KONAN | 33. ARTIFICIAL INTELLIGENCE IN THORACIC IMAGING IN ABIDJAN: USE OF COMPUTER-AIDED DIAGNOSIS DURING IMAGE POST-PROCESSING BY RADIOLOGISTS. |
| Clement Korsah | 49. A clinical and ethical dilemma during radioiodine therapy for well differentiated thyroid cancer- a case report |
| 50. Radioiodine therapy in a thyrotoxic heart disease unfit for surgery- a case report | |
| Annick KOUAME-KOUTOUAN | 35. POST-RECONSTRUCTION METHOD TO CORRECT PARTIAL VOLUME EFFECT IN SPECT IMAGING |
| 32. CONTRIBUTION OF Tc99m-Labelled MIBI SCINTIGRAPHY IN THE DIAGNOSIS OF PARATHYROIDAL ADENOMY A CASE STUDY | |
| 33. ARTIFICIAL INTELLIGENCE IN THORACIC IMAGING IN ABIDJAN: USE OF COMPUTER-AIDED DIAGNOSIS DURING IMAGE POST-PROCESSING BY RADIOLOGISTS. | |
| EPSE ABOUKOUA N'GO NATHALIE KOUASSI | 31. CONTRIBUTION OF BONE RADIONUCLIDE IMAGING IN THE ETIOLOGICAL DIAGNOSIS OF A KNEE TUMOR: A CASE REPORT |
| 32. CONTRIBUTION OF Tc99m-Labelled MIBI SCINTIGRAPHY IN THE DIAGNOSIS OF PARATHYROIDAL ADENOMY A CASE STUDY | |
| 33. ARTIFICIAL INTELLIGENCE IN THORACIC IMAGING IN ABIDJAN: USE OF COMPUTER-AIDED DIAGNOSIS DURING IMAGE POST-PROCESSING BY RADIOLOGISTS. | |
| 34. INCIDENTAL MYOCARDIAL FIXATION ON BISPHOSPHONATE BONE SCAN: TWO CASES | |
| 35. POST-RECONSTRUCTION METHOD TO CORRECT PARTIAL VOLUME EFFECT IN SPECT IMAGING | |
| Dinesh Kumar S | 25. Comparative analysis and experience of various amino acid PET tracers in a tertiary neurooncology centre – indications, patterns, advantages and pitfalls. |
| Ismaheel Lawal | 7. Can FDG PET/CT be used to optimize the treatment of patients with pulmonary tuberculosis? |
| 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry | |
| 9. Imaging of PARP upregulation in small cell neuroendocrine lung carcinoma with [123I] I-PARPi SPECT/CT | |
| 5. Effectiveness of neoadjuvant [225Ac] Ac-DOTATATE therapy in inoperable locally advanced somatostatin receptor-expressing meningioma | |
| Maryke Lundie | 39. Regadenoson compared to other pharmacological stressors used in myocardial perfusion imaging (MPI) at the Department of Nuclear Medicine at a Tertiary Academic Hospital in Gauteng, South Africa. |
| Sandhya M | 25. Comparative analysis and experience of various amino acid PET tracers in a tertiary neurooncology centre – indications, patterns, advantages and pitfalls. |
| Alex Maes | 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry |
| Johncy Mahapane | 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry |
| Masha Maharaj | 36. Hepatobiliary study showing bile reflux into the gastric mucosa |
| Sara Mahieddine | 18. Role of Ga68-PSMA in the management of Prostate cancer |
| Gerschwin Malan | 15. Designing a PET/CT Facility integrated within the General Nuclear Medicine Department at Groote Schuur Hospital |
| Letjie Maserumule | 8. Initial Response to 177Lu-PSMA Radioligand Therapy in Chemotherapy-naïve Patients |
| 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry | |
| Spelele Masikane | 40. Evaluation of the added value of a diuretic renogram in the assessment of renal function prior to targeted radionuclide therapy. |
| Sphelele Masikane | 44. The case of multiple periarticular masses on bone scan |
| Matsonso Mathebula | 7. Can FDG PET/CT be used to optimize the treatment of patients with pulmonary tuberculosis? |
| Amanda Mdlophane | 21. In-house production of various forms of [225Ac]Ac-PSMA injection – a South African hospital experience |
| Johncy Mdlophane | 21. In-house production of various forms of [225Ac]Ac-PSMA injection – a South African hospital experience |
| Hanane Messaour | 19. Role of Ga68-Dotatoc the management of Neuroendocrine tumors |
| Ingrid Moagi | 7. Can FDG PET/CT be used to optimize the treatment of patients with pulmonary tuberculosis? |
| Kgomotso Mokoala | 5. Effectiveness of neoadjuvant [225Ac] Ac-DOTATATE therapy in inoperable locally advanced somatostatin receptor-expressing meningioma |
| 7. Can FDG PET/CT be used to optimize the treatment of patients with pulmonary tuberculosis? | |
| 8. Initial Response to 177Lu-PSMA Radioligand Therapy in Chemotherapy-naïve Patients | |
| 9. Imaging of PARP upregulation in small cell neuroendocrine lung carcinoma with [123I] I-PARPi SPECT/CT | |
| 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry | |
| Andrew More | 5. Effectiveness of neoadjuvant [225Ac] Ac-DOTATATE therapy in inoperable locally advanced somatostatin receptor-expressing meningioma |
| Stuart More | 12. The added value of SPECT/CT in paediatric transplant renography - a case report |
| Stuart More | 14. Utility of NETPET in identification of patients suitable for Lu-177 DOTATATE radionuclide therapy |
| 15. Designing a PET/CT Facility integrated within the General Nuclear Medicine Department at Groote Schuur Hospital | |
| Stuart More | 26. Diagnostic Performance of Tc-99m Bone Scintigraphy in the Staging of Prostate Cancer |
| Dalila Mouas | 17. Crucial role of Iodine 131 in Management of bone metastasis of differentiated thyroid cancer |
| James Erick Munyasa | 36. Hepatobiliary study showing bile reflux into the gastric mucosa |
| Erica Murce | 20. 3p-C-NETA-TATE: A potential somatostatin analogue for diagnostic and therapeutic SSTR2 targeting radiopharmaceuticals |
| Yonwaba Mzizi | 9. Imaging of PARP upregulation in small cell neuroendocrine lung carcinoma with [123I] I-PARPi SPECT/CT |
| 21. In-house production of various forms of [225Ac]Ac-PSMA injection – a South African hospital experience | |
| Honest Ndlovu | 5. Effectiveness of neoadjuvant [225Ac] Ac-DOTATATE therapy in inoperable locally advanced somatostatin receptor-expressing meningioma |
| 9. Imaging of PARP upregulation in small cell neuroendocrine lung carcinoma with [123I] I-PARPi SPECT/CT | |
| 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry | |
| Thembelihle Nxasana | 40. Evaluation of the added value of a diuretic renogram in the assessment of renal function prior to targeted radionuclide therapy. |
| Thembelihle Sinegugu Nxasana | 41. Does bone scintigraphy change clinical management in patients with Lung cancer |
| Nozipho Nyakale | 3. An in-house developed dosimetry software for lutetium-177: Masterdose |
| Nozipho Nyakale | 5. Effectiveness of neoadjuvant [225Ac] Ac-DOTATATE therapy in inoperable locally advanced somatostatin receptor-expressing meningioma |
| 37. Lu-177 PSMA as salvage therapy for Hepatocellular carcinoma | |
| Maarten Ooms | 20. 3p-C-NETA-TATE: A potential somatostatin analogue for diagnostic and therapeutic SSTR2 targeting radiopharmaceuticals |
| Diana Paez | 4. Efficacy of second 177Lu-DOTATATE PRRT course in patients with progressive GEP-NET using dual-tracer imaging with 18FDG and 68Ga-DOTA-TOC/TATE PET/CT. Results of a WARMTH multicenter study. |
| Md. Masud Parvej | 16. Evaluate the Slab Thickness of the new LINAC Bunker as Shielding at the INMP, AERE, BAEC, Bangladesh |
| Maryam Patel | 42. Should 18F-FDG PET/CT scans (2-deoxy-2[fluorine 18] fluoro-D-glucose integrated with computed tomography) replace 99m Tc-MDP (methylene diphosphonate) bone scintigraphy in the management of breast cancer patients with suspected skeletal metastases? |
| Justin Pieterse | 14. Utility of NETPET in identification of patients suitable for Lu-177 DOTATATE radionuclide therapy |
| 26. Diagnostic Performance of Tc-99m Bone Scintigraphy in the Staging of Prostate Cancer | |
| Venesen Pillay | 37. Lu-177 PSMA as salvage therapy for Hepatocellular carcinoma |
| Venesen Pillay | 38. Ga-68 DOTATATE Avid Ectopic Adrenocorticotropic Hormone Secreting Pulmonary Carcinoid Tumour detected on PET/CT |
| 42. Should 18F-FDG PET/CT scans (2-deoxy-2[fluorine 18] fluoro-D-glucose integrated with computed tomography) replace 99m Tc-MDP (methylene diphosphonate) bone scintigraphy in the management of breast cancer patients with suspected skeletal metastases? | |
| Venessen Pillay | 44. The case of multiple periarticular masses on bone scan |
| Vladimir Polyakov | 6. Review of international (ATA 2015 and ETA 2022) and Russian recommendations for radioiodine therapy in children with differentiated thyroid cancer. |
| Gbenga Popoola | 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry |
| Skander Rahabi | 17. Crucial role of Iodine 131 in Management of bone metastasis of differentiated thyroid cancer |
| 18. Role of Ga68-PSMA in the management of Prostate cancer | |
| Abdur Rahim | 16. Evaluate the Slab Thickness of the new LINAC Bunker as Shielding at the INMP, AERE, BAEC, Bangladesh |
| Keamogetswe Ramonaheng | 27. Comparison of two dosimetry software programs for Lu-177 DOTATATE therapy using patient-specific voxel-based phantom models. |
| Janet Reed | 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry |
| Margarida Rodrigues | 4. Efficacy of second 177Lu-DOTATATE PRRT course in patients with progressive GEP-NET using dual-tracer imaging with 18FDG and 68Ga-DOTA-TOC/TATE PET/CT. Results of a WARMTH multicenter study. |
| Ilya Romanov | 2. Treatment of papillary thyroid microcarcinoma metastasis to the sternum: a case report. |
| Rita Sakala | 39. Regadenoson compared to other pharmacological stressors used in myocardial perfusion imaging (MPI) at the Department of Nuclear Medicine at a Tertiary Academic Hospital in Gauteng, South Africa. |
| Patrick Sandach | 14. Utility of NETPET in identification of patients suitable for Lu-177 DOTATATE radionuclide therapy |
| Mike Sathekge | 7. Can FDG PET/CT be used to optimize the treatment of patients with pulmonary tuberculosis? |
| Mike Sathekge | 8. Initial Response to 177Lu-PSMA Radioligand Therapy in Chemotherapy-naïve Patients |
| 21. In-house production of various forms of [225Ac]Ac-PSMA injection – a South African hospital experience | |
| 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry | |
| 29. Multimodality Imaging Possibilities of Therapeutic Isotopes in the Preclinical Setting | |
| 37. Lu-177 PSMA as salvage therapy for Hepatocellular carcinoma | |
| 5. Effectiveness of neoadjuvant [225Ac] Ac-DOTATATE therapy in inoperable locally advanced somatostatin receptor-expressing meningioma | |
| 9. Imaging of PARP upregulation in small cell neuroendocrine lung carcinoma with [123I] I-PARPi SPECT/CT | |
| Yann Seimbille | 20. 3p-C-NETA-TATE: A potential somatostatin analogue for diagnostic and therapeutic SSTR2 targeting radiopharmaceuticals |
| Helen Silva | 24. 177Lu-PSMA-617 IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER: EXPERIENCE IN URUGUAY |
| Enzo Silvera | 24. 177Lu-PSMA-617 IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER: EXPERIENCE IN URUGUAY |
| Keerti Sitani | 25. Comparative analysis and experience of various amino acid PET tracers in a tertiary neurooncology centre – indications, patterns, advantages and pitfalls. |
| Liani Smith | 29. Multimodality Imaging Possibilities of Therapeutic Isotopes in the Preclinical Setting |
| Rd Erwin Soerjadikoesoemah | 23. Hyperparathyroidism and multiple pathological fracture caused by parathyroid carcinoma : A case report |
| YOH ESTHER SORO | 31. CONTRIBUTION OF BONE RADIONUCLIDE IMAGING IN THE ETIOLOGICAL DIAGNOSIS OF A KNEE TUMOR: A CASE REPORT |
| 34. INCIDENTAL MYOCARDIAL FIXATION ON BISPHOSPHONATE BONE SCAN: TWO CASES | |
| Nahida Sultana | 16. Evaluate the Slab Thickness of the new LINAC Bunker as Shielding at the INMP, AERE, BAEC, Bangladesh |
| Sarmin Sultana | 16. Evaluate the Slab Thickness of the new LINAC Bunker as Shielding at the INMP, AERE, BAEC, Bangladesh |
| Beverley Summers | 39. Regadenoson compared to other pharmacological stressors used in myocardial perfusion imaging (MPI) at the Department of Nuclear Medicine at a Tertiary Academic Hospital in Gauteng, South Africa. |
| Cecile Swanepoel | 29. Multimodality Imaging Possibilities of Therapeutic Isotopes in the Preclinical Setting |
| Djawida Tahmi | 18. Role of Ga68-PSMA in the management of Prostate cancer |
| Amel Taïbi | 18. Role of Ga68-PSMA in the management of Prostate cancer |
| 19. Role of Ga68-Dotatoc the management of Neuroendocrine tumors | |
| Abdelkrim Talbi | 17. Crucial role of Iodine 131 in Management of bone metastasis of differentiated thyroid cancer |
| Antonio TRAINO | 35. POST-RECONSTRUCTION METHOD TO CORRECT PARTIAL VOLUME EFFECT IN SPECT IMAGING |
| Alexandra Tyulyandina | 2. Treatment of papillary thyroid microcarcinoma metastasis to the sternum: a case report. |
| Sharjeel Usmani | 1. Physiological F-18 FDG Uptake in Normal Pituitary Gland on Digital PET Scanner |
| Aslan Valiev | 2. Treatment of papillary thyroid microcarcinoma metastasis to the sternum: a case report. |
| Chris van de Wiele | 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry |
| Johannes Van Staden | 27. Comparison of two dosimetry software programs for Lu-177 DOTATATE therapy using patient-specific voxel-based phantom models. |
| Bronwin Van Wyk | 3. An in-house developed dosimetry software for lutetium-177: Masterdose |
| Mboyo-Di-Tamba Vangu | 3. An in-house developed dosimetry software for lutetium-177: Masterdose |
| Irene Virgolini | 4. Efficacy of second 177Lu-DOTATATE PRRT course in patients with progressive GEP-NET using dual-tracer imaging with 18FDG and 68Ga-DOTA-TOC/TATE PET/CT. Results of a WARMTH multicenter study. |
| Mariza Vorster | 28. The cancer associated fibroblast and hypoxia nexus: Correlation between 68Ga-FAPI PET and Hypoxia inducible factor-1alpha immunohistochemistry |
| Lukas Wirth | 13. News from Theragnostics in Children with Neuroblastoma |
| Miriam Yartey | 45. Overview of radiopharmaceutical therapy in Ghana |
| Miriam Yartey | 46. DURATION AND FACTORS AFFECTING THE OUTCOME OF RADIOIODINE TREATMENT OF HYPERTHYROIDISM |
| 47. Toxic retrosternal goitre treated with radioiodine- a case report | |
| 48. Paradoxical decrease in TSH level during thyroxine withdrawal for radioiodine therapy for well differentiated thyroid cancer- a case report | |
| 49. A clinical and ethical dilemma during radioiodine therapy for well differentiated thyroid cancer- a case report | |
| 30. EFFECT OF A SINGLE DOSE OF RADIOIODINE THERAPY ON PRIMARY HYPERTHYROIDISM PATIENTS IN GHANA. | |
| Jan-Rijn Zeevaart | 29. Multimodality Imaging Possibilities of Therapeutic Isotopes in the Preclinical Setting |
| ERIC ZUNON-KIPRE | 32. CONTRIBUTION OF Tc99m-Labelled MIBI SCINTIGRAPHY IN THE DIAGNOSIS OF PARATHYROIDAL ADENOMY A CASE STUDY |
Powered by Phoca Download